However, MTAP homozygous deletion represents a relatively late genetic event in the tumor progression, which may confer survival advantage to aggressive subclones of myxofibrosarcoma cells and thereby culminate in negative prognostic impact. This evidence concerns the gene MTAP and neoplasm.